ARCHIVES

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

DCT Board Okays Six Contract Recompetitions

October 23, 1987

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients

December 4, 1981